China National Accord Medicines Corporation Ltd. (SHE:000028)
China · Delayed Price · Currency is CNY 24.53
+0.01 (0.04%)
May 8, 2026, 3:04 PM CST
SHE:000028 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,095 | 1,136 | 642.49 | 1,599 | 1,487 | 1,336 |
Depreciation & Amortization | 1,229 | 1,229 | 1,545 | 1,426 | 1,307 | 1,242 |
Other Amortization | 200.02 | 200.02 | 198.4 | 163.56 | 180.31 | 188.65 |
Loss (Gain) From Sale of Assets | -7.96 | -7.96 | -11.87 | -45.31 | -6.26 | -2.7 |
Asset Writedown & Restructuring Costs | 285.76 | 285.76 | 971.84 | 0.63 | 55.64 | 236.84 |
Loss (Gain) From Sale of Investments | -294.38 | -294.38 | -356.87 | -309.08 | -28.87 | - |
Provision & Write-off of Bad Debts | 83.95 | 83.95 | 94.15 | 71.36 | 29.77 | 44.22 |
Other Operating Activities | -879.94 | 197.59 | -119.54 | 630.83 | 357.4 | 131.94 |
Change in Accounts Receivable | -1,484 | -1,484 | -965.33 | -3,992 | 1,227 | -2,121 |
Change in Inventory | -721.59 | -721.59 | 559.6 | -170.13 | -217.84 | -1,260 |
Change in Accounts Payable | 1,309 | 1,309 | 463.05 | 3,688 | -1,949 | 2,135 |
Change in Other Net Operating Assets | -213.62 | -213.62 | 305.42 | -79.9 | 193.22 | -203.6 |
Operating Cash Flow | 520.53 | 1,639 | 3,271 | 2,937 | 2,560 | 1,655 |
Operating Cash Flow Growth | -75.08% | -49.91% | 11.38% | 14.71% | 54.69% | 10.14% |
Capital Expenditures | -180.01 | -217.35 | -282.7 | -322.21 | -322.19 | -370.43 |
Sale of Property, Plant & Equipment | 2.3 | 1.82 | 1.2 | 37.88 | 4.94 | 1.02 |
Cash Acquisitions | -7.42 | -7.42 | -71.4 | - | -126.35 | -109.95 |
Divestitures | - | - | - | 3.23 | - | - |
Investment in Securities | 19.35 | 20.94 | 6.58 | -3.72 | 89.66 | -144.03 |
Other Investing Activities | 99.58 | 99.09 | 195.63 | 149.38 | 11.12 | 167.86 |
Investing Cash Flow | -66.2 | -102.92 | -150.69 | -135.43 | -342.82 | -455.53 |
Short-Term Debt Issued | - | 1,672 | 1,560 | 1,873 | - | 81.45 |
Long-Term Debt Issued | - | - | - | 4 | 1,520 | 932.68 |
Total Debt Issued | 1,784 | 1,672 | 1,560 | 1,877 | 1,520 | 1,014 |
Short-Term Debt Repaid | - | -1,531 | -1,575 | -2,363 | -72.45 | -65.7 |
Long-Term Debt Repaid | - | -1,026 | -1,224 | -1,272 | -2,629 | -2,100 |
Total Debt Repaid | -2,436 | -2,558 | -2,799 | -3,635 | -2,701 | -2,165 |
Net Debt Issued (Repaid) | -651.62 | -885.17 | -1,239 | -1,758 | -1,181 | -1,151 |
Issuance of Common Stock | - | - | - | 31.6 | - | - |
Common Dividends Paid | -376.45 | -386.29 | -603.77 | -559.07 | -574.19 | -610.54 |
Other Financing Activities | -93.82 | -90.76 | 11.29 | -121.87 | 247.65 | -109.86 |
Financing Cash Flow | -1,122 | -1,362 | -1,831 | -2,408 | -1,508 | -1,872 |
Foreign Exchange Rate Adjustments | -0.08 | -0.07 | -1.2 | -0.94 | -1.19 | 0.39 |
Net Cash Flow | -667.64 | 173.36 | 1,288 | 393.12 | 708.66 | -671.6 |
Free Cash Flow | 340.51 | 1,421 | 2,989 | 2,615 | 2,238 | 1,285 |
Free Cash Flow Growth | -81.22% | -52.45% | 14.30% | 16.83% | 74.22% | 6.27% |
Free Cash Flow Margin | 0.47% | 1.94% | 4.02% | 3.46% | 3.05% | 1.88% |
Free Cash Flow Per Share | 0.61 | 2.55 | 5.35 | 4.69 | 4.02 | 2.31 |
Cash Income Tax Paid | 1,761 | 1,736 | 1,771 | 1,887 | 1,782 | 1,564 |
Levered Free Cash Flow | 1,984 | 2,014 | 1,992 | 877.02 | 2,410 | 135.8 |
Unlevered Free Cash Flow | 2,106 | 2,135 | 2,154 | 1,032 | 2,573 | 315.83 |
Change in Working Capital | -1,192 | -1,192 | 307.52 | -599.77 | -821.69 | -1,523 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.